The Sigma1 Protein as a Target for the Non-genomic Effects of Neuro(active)steroids: Molecular, Physiological, and Behavioral AspectsFrançois P. Monnet(Hôpital Fernand-Widal), Tangui Maurice(Boehringer Ingelheim (France))Journal of Pharmacological SciencesJanuary 1, 200610.1254/jphs.cr0050032Cited by 164SaveCiteExport RISWatch citationsRelated PapersMitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25–35 peptide-injected mice, a nontransgenic Alzheimer’s disease model|Frontiers in Cellular Neuroscience|2015|79